Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Lucinactant> ?p ?o. }
Showing items 1 to 28 of
28
with 100 items per page.
- Lucinactant abstract "Lucinactant (trade name Surfaxin) is a liquid medication used to treat Infant Respiratory Distress Syndrome in infants. It was approved for use in the United States by the U.S. Food and Drug Administration (FDA) on March 6, 2012.".
- Lucinactant atcPrefix "R07".
- Lucinactant atcSuffix "AA30".
- Lucinactant casNumber "825600-90-6".
- Lucinactant wikiPageID "25933137".
- Lucinactant wikiPageRevisionID "587770385".
- Lucinactant atcPrefix "R07".
- Lucinactant atcSuffix "AA30".
- Lucinactant casNumber "825600".
- Lucinactant component "1".
- Lucinactant component "Dipalmitoylphosphatidylcholine".
- Lucinactant component "Sinapultide".
- Lucinactant component "palmitic acid".
- Lucinactant hasPhotoCollection Lucinactant.
- Lucinactant tradename "Surfaxin".
- Lucinactant type "combo".
- Lucinactant subject Category:Drugs_acting_on_the_respiratory_system.
- Lucinactant subject Category:Pediatrics.
- Lucinactant subject Category:Respiratory_and_cardiovascular_disorders_specific_to_the_perinatal_period.
- Lucinactant type Drug.
- Lucinactant type FunctionalSubstance.
- Lucinactant comment "Lucinactant (trade name Surfaxin) is a liquid medication used to treat Infant Respiratory Distress Syndrome in infants. It was approved for use in the United States by the U.S. Food and Drug Administration (FDA) on March 6, 2012.".
- Lucinactant label "Lucinactant".
- Lucinactant sameAs m.0cm9mmh.
- Lucinactant sameAs Q6697358.
- Lucinactant sameAs Q6697358.
- Lucinactant wasDerivedFrom Lucinactant?oldid=587770385.
- Lucinactant isPrimaryTopicOf Lucinactant.